Alpha Tribe
FeedCompaniesAgentsSubscribe

Filter announcements

  • All
  • Important
  • Results
  • Board Meeting
  • New Orders
  • QIP/Rights/Pref.
  • PPTs
  • JV/Acquisition
  • Insider Trade
  • Dividend/Bonus
  • Credit Ratings
  • Updates
  • Pledging
  • Investor Meet
  • Others

Download our app

Best experience on mobile

Get it on Google PlayDownload on the App Store

Join 5K+ users on Alpha Tribe

Loading...
Bal Pharma Limited logo

Bal Pharma Limited

BALPHARMA·Pharmaceuticals

Incorporated in 1987, Bal Pharma Ltd does manufacturing and selling of pharmaceutical products and related services

79Announcements
10-09-2026Last filed
15Last 90 days

What Bal files

  • Others47
  • Updates9
  • Important9
  • Board Meeting8
  • Dividend/Bonus4
  • Results2
Showing Important announcements (9)Clear filter
24-06-2026 · 05:31 pm

Bal Pharma announces Mr. Shreepada ML has commenced duties as Company Secretary and Compliance Officer, taking charge as a Key Managerial Personnel. This strengthens the company's corporate governance.

Read the full announcement→
PDF
16-06-2025 · 04:57 pm

Bal Pharma Limited urges shareholders with physical shares to update KYC details like PAN, bank info, and contact through multiple submission options to ensure smooth dividend credit and future electronic payments. No operational or financial impact reported.

Read the full announcement→
PDF
18-04-2025 · 10:38 am

Bal Pharma Limited has withdrawn its application for the reclassification of promoter Ms. Anita Chandraprakash Siroya. This decision comes after discussions with the listing compliance teams of BSE and NSE, considering that she holds more than 10% of the voting rights in the company, which is governed by Regulation 31A...

Read the full announcement→
PDF
20-03-2025 · 11:36 am

Bal Pharma has withdrawn its application for the reclassification of promoters Mr. Shrenik D. Siroya and Ms. Jivi Dheerajmal Siroya, as they hold more than 10% of the voting rights in the company, per SEBI regulations. This decision may help maintain stability in the company's governance structure, ensuring that key...

Read the full announcement→
PDF
24-02-2025 · 03:09 pm

**Updates:** Bal Pharma Limited has resubmitted its unaudited financial results for the quarter ended December 31, 2024. Revenue from operations for the quarter stood at ₹7,288.52 Cr, a decrease from ₹8,149.46 Cr during the same quarter last year. Total income for the period was ₹7,370.49 Cr, reflecting a decline compared...

Read the full announcement→
PDF